Y. Ge

发表

Identification of highly potent BTK and JAK3 dual inhibitors with improved activity for the treatment of B-cell lymphoma.

Xiaodong Ma, Zhihao Liu, Q. Meng, 2018, European journal of medicinal chemistry.

A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists.

J. Wood, T. Coderre, P. Schiller, 2016, Journal of medicinal chemistry.

Benzophenone Derivatives : a Novel Scaffold as Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors

Xiaodong Ma, Jiasheng Xu, Zhendong Song, 2016 .

Novel 4-anilinoquinazoline derivatives featuring an 1-adamantyl moiety as potent EGFR inhibitors with enhanced activity against NSCLC cell lines.

Xiaodong Ma, Yue Jin, Xu Han, 2016, European journal of medicinal chemistry.

Challenges and Perspectives on the Development of Small-Molecule EGFR Inhibitors against T790M-Mediated Resistance in Non-Small-Cell Lung Cancer.

Xiaodong Ma, Youwen Zhou, Changyuan Wang, 2016, Journal of medicinal chemistry.

Synthesis and biological evaluation of azole-diphenylpyrimidine derivatives (AzDPPYs) as potent T790M mutant form of epidermal growth factor receptor inhibitors.

Jinyong Peng, Xiaodong Ma, Yue Jin, 2016, Bioorganic & medicinal chemistry.

Design and synthesis of phosphoryl-substituted diphenylpyrimidines (Pho-DPPYs) as potent Bruton's tyrosine kinase (BTK) inhibitors: Targeted treatment of B lymphoblastic leukemia cell lines.

Huijun Sun, Xiaodong Ma, Q. Meng, 2017, Bioorganic & medicinal chemistry.

Discovery of Novel Bruton's Tyrosine Kinase (BTK) Inhibitors Bearing a N,9-Diphenyl-9H-purin-2-amine Scaffold.

Xiaodong Ma, Changyuan Wang, Jinyong Peng, 2016, ACS medicinal chemistry letters.

Phosphamide-containing diphenylpyrimidine analogues (PA-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with enhanced activity against pancreatic cancer cell lines.

Xiaodong Ma, Bin Wu, Changyuan Wang, 2017, Bioorganic & medicinal chemistry.

C-2 (E)-4-(Styryl)aniline substituted diphenylpyrimidine derivatives (Sty-DPPYs) as specific kinase inhibitors targeting clinical resistance related EGFRT790M mutant.

Jinyong Peng, Xiaodong Ma, Q. Meng, 2017, Bioorganic & medicinal chemistry.